Ratings by Benchmark (Robert Wasserman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/21/2026 | Kamada Ltd. | KMDA | Maintain | Buy (Buy) |
|
Details | ||
| 7/21/2026 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 7/16/2026 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Repligen | RGEN | Upgrade | Buy (Hold) |
141.46 (145.34) |
2.74% | Details | |
| 7/7/2026 | AbCellera Biologics | ABCL | Upgrade | Buy (Hold) |
7.87 (5.29) |
-32.78% | Details | |
| 7/6/2026 | Proto Labs | PRLB | Maintain | Buy (Buy) |
|
Details | ||
| 6/30/2026 | Bio-Techne Corp. | TECH | Downgrade | Hold (Buy) |
70.90 (72.07) |
1.65% | Details | |
| 6/3/2026 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2026 | Emergent BioSolutions | EBS | Maintain | Buy (Buy) |
|
Details | ||
| 5/22/2026 | XOMA, Ltd. | XOMA | Downgrade | Hold (Buy) |
41.82 (40.17) |
-3.95% | Details | |
| 5/20/2026 | Intensity Therapeutics, Inc. | INTS | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 5/19/2026 | Kamada Ltd. | KMDA | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2026 | Codexis, Inc. | CDXS | Maintain | Hold (Hold) |
|
Details | ||
| 3/18/2026 | Nephros | NEPH | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 3/17/2026 | MindWalk Holdings | HYFT | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 3/12/2026 | Kamada Ltd. | KMDA | Maintain | Buy (Buy) |
|
Details | ||
| 3/6/2026 | OmniAb, Inc. | OABI | Maintain | Buy (Buy) |
|
Details | ||
| 2/20/2026 | Integer Holding | ITGR | Upgrade | Buy (Hold) |
83.00 (100.38) |
20.94% | Details | |
| 2/19/2026 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2026 | Proto Labs | PRLB | Maintain | Buy (Buy) |
|
Details | ||
| 2/3/2026 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 2/3/2026 | Bio-Techne Corp. | TECH | Maintain | Buy (Buy) |
|
Details | ||
| 1/8/2026 | Kamada Ltd. | KMDA | Maintain | Buy (Buy) |
|
Details | ||
| 12/12/2025 | XOMA, Ltd. | XOMA | Maintain | Buy (Buy) |
|
Details | ||
| 12/10/2025 | Ligand Pharma | LGND | Maintain | Buy (Buy) |
|
Details | ||
| 11/7/2025 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | OmniAb, Inc. | OABI | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2025 | Proto Labs | PRLB | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2025 | Integer Holding | ITGR | Downgrade | Hold (Buy) |
73.89 (100.38) |
35.85% | Details | |
| 9/24/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (Buy) |
|
Details | ||
| 9/9/2025 | XOMA, Ltd. | XOMA | Maintain | Buy (Buy) |
|
Details | ||
| 9/2/2025 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2025 | Intensity Therapeutics, Inc. | INTS | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 8/19/2025 | Codexis, Inc. | CDXS | Maintain | Hold (Hold) |
|
Details | ||
| 8/14/2025 | Kamada Ltd. | KMDA | Maintain | Buy (Buy) |
|
Details | ||
| 8/13/2025 | AbCellera Biologics | ABCL | Maintain | Hold (Hold) |
|
Details | ||
| 8/12/2025 | Nephros | NEPH | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 8/8/2025 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2025 | Integer Holding | ITGR | Maintain | Buy (Buy) |
|
Details | ||
| 6/5/2025 | Bio-Techne Corp. | TECH | Maintain | Buy (Buy) |
|
Details | ||
| 5/22/2025 | Anebulo Pharmaceuticals | ANEB | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 5/21/2025 | Intensity Therapeutics, Inc. | INTS | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 5/15/2025 | Kamada Ltd. | KMDA | Maintain | Buy (Buy) |
|
Details | ||
| 5/8/2025 | Bio-Techne Corp. | TECH | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2025 | Halozyme Therapeutics | HALO | Maintain | Hold (Hold) |
|
Details | ||
| 5/5/2025 | Proto Labs | PRLB | Maintain | Buy (Buy) |
|
Details | ||
| 4/25/2025 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2025 | XOMA, Ltd. | XOMA | New Coverage | Buy (N/A) |
20.53 (41.82) |
103.7% | Details | |
| 4/1/2025 | Immunoprecise Antibodies Ltd. | IPA | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 3/21/2025 | Kamada Ltd. | KMDA | New Coverage | Buy (N/A) |
6.65 (7.06) |
6.17% | Details | |
| 3/20/2025 | OmniAb, Inc. | OABI | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2025 | Intensity Therapeutics, Inc. | INTS | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 3/4/2025 | BioLife Solutions | BLFS | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2025 | AbCellera Biologics | ABCL | Maintain | Hold (Hold) |
|
Details | ||
| 2/24/2025 | Repligen | RGEN | Maintain | Hold (Hold) |
|
Details | ||
| 2/21/2025 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Proto Labs | PRLB | Maintain | Buy (Buy) |
|
Details | ||
| 1/23/2025 | Immunoprecise Antibodies Ltd. | IPA | Maintain | Buy (Buy) |
|
Details | ||
| 12/23/2024 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2024 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2024 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2024 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2024 | Integer Holding | ITGR | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2024 | Anebulo Pharmaceuticals | ANEB | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 8/22/2024 | Nephros | NEPH | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 8/20/2024 | AbCellera Biologics | ABCL | Downgrade | Hold (Buy) |
2.71 (7.87) |
190.41% | Details | |
| 8/19/2024 | Codexis, Inc. | CDXS | Downgrade | Hold (Buy) |
2.91 (1.50) |
-48.45% | Details | |
| 8/14/2024 | Immunoprecise Antibodies Ltd. | IPA | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 6/25/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 6/20/2024 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | BioLife Solutions | BLFS | Upgrade | Buy (Neutral) |
19.54 (31.98) |
63.66% | Details | |
| 3/28/2024 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | Nephros | NEPH | Upgrade | Speculative Buy (Hold) |
3.02 (3.50) |
15.89% | Details | |
| 3/7/2024 | Emergent BioSolutions | EBS | Upgrade | Buy (Hold) |
3.26 (7.31) |
124.23% | Details | |
| 2/29/2024 | Codexis, Inc. | CDXS | Upgrade | Buy (Hold) |
3.72 (1.50) |
-59.68% | Details | |
| 2/22/2024 | AbCellera Biologics | ABCL | Upgrade | Buy (Hold) |
4.81 (5.29) |
9.98% | Details | |
| 12/4/2023 | Repligen | RGEN | Downgrade | Hold (Buy) |
164.94 (141.46) |
-14.24% | Details | |
| 11/7/2023 | Codexis, Inc. | CDXS | Downgrade | Hold (Buy) |
1.75 (1.50) |
-14.29% | Details | |
| 11/6/2023 | AbCellera Biologics | ABCL | Downgrade | Hold (Buy) |
4.70 (5.29) |
12.55% | Details | |
| 11/1/2023 | Bio-Techne Corp. | TECH | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2023 | AbCellera Biologics | ABCL | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2023 | Emergent BioSolutions | EBS | Downgrade | Hold (Buy) |
4.42 (7.31) |
65.38% | Details | |
| 8/25/2023 | Molekule Group, Inc. | MKUL | Downgrade | Hold (Buy) |
1.19 (0.05) |
-95.8% | Details | |
| 7/28/2023 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2023 | Intensity Therapeutics, Inc. | INTS | New Coverage | Speculative Buy (N/A) |
5.89 (4.55) |
-22.75% | Details | |
| 5/10/2023 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2023 | OmniAb, Inc. | OABI | New Coverage | Buy (N/A) |
3.59 (1.97) |
-45.13% | Details | |
| 4/10/2023 | Emergent BioSolutions | EBS | Upgrade | Buy (Hold) |
10.56 (7.31) |
-30.78% | Details | |
| 3/28/2023 | Repligen | RGEN | New Coverage | Buy (N/A) |
160.25 (164.94) |
2.93% | Details | |
| 3/21/2023 | Immunoprecise Antibodies Ltd. | IPA | Downgrade | Speculative Buy (Buy) |
3.08 (2.07) |
-32.79% | Details | |
| 3/16/2023 | Champions Oncology | CSBR | Downgrade | Hold (Buy) |
4.10 (5.53) |
34.88% | Details | |
| 2/14/2023 | Anebulo Pharmaceuticals | ANEB | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 2/13/2023 | Proto Labs | PRLB | Upgrade | Buy (Hold) |
34.43 (74.88) |
117.48% | Details | |
| 12/8/2022 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | AeroClean Thechnologies Inc. | AERC | Downgrade | Speculative Buy (Buy) |
3.27 (3.40) |
3.98% | Details | |
| 11/10/2022 | Emergent BioSolutions | EBS | Downgrade | Hold (Buy) |
12.85 (7.31) |
-43.11% | Details | |
| 11/2/2022 | Bio-Techne Corp. | TECH | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2022 | Thor Industries Inc. | THO | Downgrade | Hold (Buy) |
79.27 (79.28) |
0.01% | Details | |
| 10/24/2022 | Danaher | DHR | Downgrade | Hold (Buy) |
244.59 (199.05) |
-18.62% | Details | |
| 8/18/2022 | AeroClean Thechnologies Inc. | AERC | Upgrade | Speculative Buy (Hold) |
4.34 (3.40) |
-21.66% | Details | |
| 7/15/2022 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2022 | AeroClean Thechnologies Inc. | AERC | Downgrade | Hold (Buy) |
17.25 (4.34) |
-74.84% | Details | |
| 6/7/2022 | AeroClean Thechnologies Inc. | AERC | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 5/17/2022 | Anebulo Pharmaceuticals | ANEB | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 5/9/2022 | Nephros | NEPH | Downgrade | Hold (Speculative Buy) |
2.21 (3.50) |
58.37% | Details | |
| 2/22/2022 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2022 | AeroClean Thechnologies Inc. | AERC | New Coverage | Speculative Buy (N/A) |
4.94 (17.25) |
249.19% | Details | |
| 1/20/2022 | Emergent BioSolutions | EBS | Upgrade | Buy (Neutral) |
45.59 (7.31) |
-83.97% | Details | |
| 12/21/2021 | AbCellera Biologics | ABCL | New Coverage | Buy (N/A) |
14.60 (5.29) |
-63.77% | Details | |
| 11/8/2021 | Emergent BioSolutions | EBS | Downgrade | Hold (Buy) |
52.61 (7.31) |
-86.11% | Details | |
| 10/29/2021 | Proto Labs | PRLB | Downgrade | Hold (Buy) |
58.64 (34.43) |
-41.29% | Details | |
| 10/25/2021 | Immunoprecise Antibodies Ltd. | IPA | New Coverage | Buy (N/A) |
6.19 (2.07) |
-66.56% | Details | |
| 9/22/2021 | Thermo Fisher Scientific | TMO | Maintain | Hold (N/A) |
|
Details | ||
| 7/16/2021 | Danaher | DHR | New Coverage | Buy (N/A) |
280.95 (199.05) |
-29.15% | Details | |
| 7/16/2021 | Thermo Fisher Scientific | TMO | New Coverage | Buy (N/A) |
514.48 (576.41) |
12.04% | Details | |
| 5/25/2021 | Anebulo Pharmaceuticals | ANEB | New Coverage | Buy (N/A) |
8.00 (0.36) |
-95.5% | Details | |
| 5/14/2021 | BioLife Solutions | BLFS | Downgrade | Neutral (Buy) |
29.53 (31.98) |
8.3% | Details | |
| 4/13/2021 | Bio-Techne Corp. | TECH | Maintain | Buy (N/A) |
|
Details | ||
| 4/7/2021 | Emergent BioSolutions | EBS | New Coverage | Buy (N/A) |
79.25 (7.31) |
-90.78% | Details | |
| 3/23/2021 | BioLife Solutions | BLFS | Upgrade | Buy (Hold) |
38.57 (31.98) |
-17.09% | Details | |
| 1/21/2021 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | BioLife Solutions | BLFS | Downgrade | Hold (Buy) |
22.57 (31.98) |
41.69% | Details | |
| 7/15/2020 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2020 | Halozyme Therapeutics | HALO | New Coverage | Buy (N/A) |
26.81 (83.45) |
211.26% | Details | |
| 5/14/2020 | Bio-Techne Corp. | TECH | New Coverage | Buy (N/A) |
261.83 (70.90) |
-72.92% | Details | |
| 5/14/2020 | Proto Labs | PRLB | New Coverage | Buy (N/A) |
96.62 (58.64) |
-39.31% | Details | |
| 5/14/2020 | Integer Holding | ITGR | New Coverage | Buy (N/A) |
70.64 (73.89) |
4.6% | Details | |
| 3/10/2020 | Codexis, Inc. | CDXS | New Coverage | Buy (N/A) |
11.43 (1.50) |
-86.88% | Details | |
| 2/19/2020 | BioLife Solutions | BLFS | New Coverage | (N/A) |
15.54 (31.98) |
105.79% | Details | |
| 2/6/2020 | Ligand Pharma | LGND | New Coverage | Buy (N/A) |
92.19 (296.28) |
221.38% | Details | |
| 11/18/2019 | Champions Oncology | CSBR | New Coverage | Speculative Buy (N/A) |
5.39 (5.53) |
2.6% | Details | |
| 10/24/2019 | Nephros | NEPH | New Coverage | Speculative Buy (N/A) |
9.61 (3.50) |
-63.58% | Details |
